Benatti Luca
Quince Therapeutics, Inc. · Director
Benatti Luca is listed in filings as Director at Quince Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 29, 2025, including sale activity. Recent filings connect the profile to Quince Therapeutics, Inc. (QNCX). The current snapshot covers public activity from Jun 6, 2025 to Dec 29, 2025. Reported amounts are shown as $173.5K to $29.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $174k50k shares | SellDec 26, 2025 | $3.47 | $18.82 |